Serina Therapeutics, Inc. (SER) › Operating IncomeSerina Therapeutics, Inc. (SER) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$6.66M2018: -$11.24M2019: -$12.56M2020: -$10.10M2021: -$7.93M2022: -$6.97M2023: -$3.13M2024: -$17.05M2025: -$24.02M-$24.02M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$24.02M-40.9%2024-$17.05M-444.8%2023-$3.13M+55.1%2022-$6.97M+12.1%2021-$7.93M+21.5%2020-$10.10M+19.6%2019-$12.56M-11.7%2018-$11.24M-68.8%2017-$6.66M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share